Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-075484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-05-20 | 2025-05-16 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $74.17 | -32.3K | 5,487 | -85% | -$2.39M |
| DT | 2025-05-20 | 2025-05-16 | CORT | Guyer William | Chief Development Off | M - OptEx | $21.65 | +32.3K | 37.7K | +588% | +$698.5K |
| DT | 2025-05-20 | 2025-05-16 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -32.3K | 410.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | S | D | 32,262 | $74.17 | 5,487 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.94 to $74.66 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2025-05-16 | M | A | 32,262 | $21.65 | 37,749 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-05-16 | M | D | 32,262 | $0.00 | 410,000 | D | $21.65 · — to 2031-09-01 | 32,262 Common Stock | (F3) Fully exercisable. |